Seeking Alpha

lspiteri

lspiteri
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Inovio continues sharply lower after secondary offering [View news story]
    It came out at $2.90. I thought it would go down more
    Feb 27, 2014. 09:03 PM | 1 Like Like |Link to Comment
  • Inovio continues sharply lower after secondary offering [View news story]
    I thought it would go down more since the offering was priced at $2.90
    Feb 27, 2014. 09:03 PM | 1 Like Like |Link to Comment
  • Microcap pharmaceutical developer NovaBay (NBY +11.7%) pops after launching its Phase II trial of its NVC-422 for viral conjunctivitis. Roth Capital expects the results of the study to be positive, and says recent weakness in the shares have created a buying opportunity.  [View news story]
    How long do they test phase ll ?
    May 18, 2012. 08:17 AM | Likes Like |Link to Comment
COMMENTS STATS
3 Comments
2 Likes